Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
US stocks close | US PCE inflation cools down, S&P Nasdaq falls but Dow hits new high; China concept index surges 24% for the whole week, jd.com hits fourteen-month high.
US PCE inflation cooling solidifies the confidence of the Fed in rate cuts, but US stocks fell in the afternoon, with nvidia dropping nearly 4% at one point. China's stimulus policies drove the Chinese concept index up by 4%, nio inc rose by nearly 13%, pan-European stock indexes and German stocks hit new highs for two consecutive days, luxury goods stocks rose again. The Dow, S&P, and Nasdaq have all risen for three consecutive weeks, with two China-focused ETFs achieving the best weekly gains in history.
AT&T Inc. 4.750% PFD SER C Declares $0.2968 Dividend
J&J Releases Encouraging Data on Talvey Combination Therapies
Achieve, INmune, Lenz Gain on Bullish Initiations From Raymond James
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Forecasting The Future: 13 Analyst Projections For AT&T
AT&T Analyst Ratings
Agios Cut at Leerink on Overhang From Pfizer's Oxbryta Withdrawal
Bristol-Myers Squibb Analyst Ratings
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
More Than 3M Customers Without Power as Hurricane Helene Rips Through Southeast U.S.
Biggest Stock Movers Friday: BB, BMY, and More
Bristol-Myers Wins FDA Nod for First-of-its-kind Antipsychotic
Fulcrum Therapeutics Swings up 17% on Pfizer Sickle Cell Drug Setback
Looking Into Verizon Communications's Recent Short Interest
Merck, Bristol-Myers Fail to Convince FDA AdCom on Wider Opdivo, Keytruda Use
How Is The Market Feeling About Altria Group?
Crown Castle Analyst Ratings
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths